Assure Holdings Hosts Q1 2022 Conference Call

DENVER, May 06, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Ensure”) (NASDAQ: IONM), an intraoperative neuromonitoring provider (“IONM”) and Remote Neurology Services, will hold a conference call on Monday, May 16, 2022 at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2022.

The live webcast of the conference call and related presentation slides can be accessed at ir.assureneuromonitoring.com/news-events/ir-calendar. An audio only option is available by following the connection instructions below. Investors opting for audio only will need to download the associated slides from ir.assureneuromonitoring.com/company-information/presentations.

The Company will release its financial results in a press release prior to the conference call.

When: Monday, May 16, 2022
Time: 4:30 p.m. Eastern Time (2:30 p.m. Mountain Time)
Toll free: 1-877-300-8521
International dial-in number: 1-412-317-6026
Conference ID: 10166941

Please call the conference phone number 5-10 minutes before the start time. An operator will register your name and organization.

The conference call will be broadcast live and available for replay here.

A replay of the conference call will be available after 7:30 p.m. Eastern Time the same day until May 30, 2022.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 10166941

About Assure Holdings
Assure Holdings Corp. is a leading provider of outsourced intraoperative neuromonitoring and remote neurology services. The company provides a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that put the nervous system at risk, including neurosurgery, spine, cardiovascular, orthopedic and surgeries ears, nose and throat. Assure employs highly trained technologists who provide a direct point of contact in the operating room. Physicians employed by Assure affiliates simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure by communicating in real time with the surgeon and technologist. Accredited by the Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-looking statements
This press release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to, comments regarding: expectations regarding the growth and development of the Company and the quality and future service results. Forward-looking statements can generally be identified by the use of the words “anticipates”, “expects”, “intends”, “plans”, “should”, “could”, “might”, “could”. ‘, ‘will’, ‘believes’, ‘estimates’, ‘potential’, ‘target’ or ‘continues’ and variations or similar expressions. These statements are based on management’s current expectations and beliefs and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the operations and activities of the Company, its remote neurology activities and the economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our Annual Report on Form 10-K filed March 14, 2022 and available on the company’s EDGAR profile at www.sec.gov, the risks and uncertainties of which are incorporated herein by reference. Except as required by law, Assure does not intend and assumes no obligation to update forward-looking statements to reflect, in particular, new information or future events.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-617-2526
[email protected]

Michael P. Boser